Innovation for MENA poultry husbandry discussed at Boehringer Ingelheim's Annual Poultry Assembly

• The MENA has a substantial poultry population of over four billion 
• Boehringer Ingelheim Animal Health in the MENA region provides solutions that improve health in livestock, horses and poultry

Dubai, United Arab Emirates, November 2nd, 2016:  Boehringer Ingelheim, one of the world’s leading pharmaceutical companies recently held its first Annual Poultry Assembly that highlighted the epidemiology of avian diseases in the MENA region. 

The event, which was held in Berlin, included more than 100 animal healthcare professionals from the United Arab Emirates, Saudi Arabia, Egypt, Algeria, Morocco, Iraq, Jordan and Pakistan, and provided updates in control solutions related to poultry maladies in the region as well the latest vaccinations and medications outcomes. 

Dr. Mohammed Hussein, Head of Poultry META region in Boehringer Ingelheim’s said, “We are pleased to address an important topic that directly links to our daily lives and nutrition. In large parts of the world, including MENA, poultry is and will remain the fastest growing source of animal protein. To address that, this event serves as a unique platform to exchange the latest updates on solutions for the poultry industry. To protect poultry against infectious diseases, Boehringer Ingelheim works to provide sustainable animal health solutions including vaccines with proven effectiveness and safety that accommodate the region’s specific needs.”

Dr. Hussein added, “Poultry diseases affect the supply situation of animal protein if it is not controlled. To that extent, early detection, diagnosis and reporting must become a priority. Preventive vaccination is one approach to controlling any diseases. The region has applied a lot of advances in this area and our commitment is to support in the investment in a healthier poultry supply which in return would reflect in healthier communities.”

Across the MENA, Boehringer Ingelheim provides solutions that improve health in livestock, horses and poultry. With innovative biological, specialty pharmaceutical and neutraceutical products, based on its own research and development network, and industry-leading technical service veterinarians, the company is focused on serving the needs of its customers and its animal patients in the region.

The poultry sector continues to grow due to increased demand across the region. Leading industry figures during this gathering also discussed updates around common diseases in the region, which include Avian Influenza, Newcastle disease, Adeno virus and Gallibacterium anatis.